Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 7, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neurobo Pharmaceuticals, Inc.
| 5.05K |
—
|
—
| +125.62% | 9.07K |
Jun 7
| |||||||
Neurobo Pharmaceuticals, Inc.
| 32.16K |
—
|
—
|
∞
| 32.16K |
Dec 1
| |||||||
Neurobo Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Endo International Plc
| -280.37K |
—
|
—
| -100.00% |
0
| +1 |
Jul 15
| ||||||
Agile Therapeutics Inc
| 670 |
—
|
—
| +47.99% | 2.07K |
Jun 9
| |||||||
Endo International Plc
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Agile Therapeutics Inc
| 24.51K |
—
|
—
| +78.20% | 55.85K |
Jun 8
| |||||||
Agile Therapeutics Inc
| 13.39K |
—
|
—
| +74.62% | 31.34K |
Jun 9
| |||||||
Antares Pharma, Inc.
| 45.2K |
$2.92 | $131,998.60 |
∞
| 45.2K | +1 |
Jun 13
| ||||||
Agile Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 6
| |||||||
Antares Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 |
Aug 6
| ||||||
Antares Pharma, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Agile Therapeutics Inc
| 17.95K |
—
|
—
|
∞
| 17.95K |
Jun 7 - Jun 8
| |||||||
Aralez Pharmaceuticals Inc.
| -9.35K |
$0.52 | -$4,881.53 | -3.72% | 242.05K |
May 14
|
Scheduled
| ||||||
Aralez Pharmaceuticals Inc.
| -5.95K |
$1.70 | -$10,115.00 | -2.31% | 251.4K |
Mar 19
|
Scheduled
| ||||||
Aralez Pharmaceuticals Inc.
| -9.96K |
$2.50 | -$24,917.93 | -3.73% | 257.35K |
Oct 2
|
Scheduled
| ||||||
Agile Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Aralez Pharmaceuticals Inc.
| 83.19K |
—
|
—
| +45.18% | 267.31K |
May 11
| |||||||
Aralez Pharmaceuticals Inc.
| 4.75K |
$2.11 | $10,022.50 | +2.65% | 184.12K |
Mar 15
| |||||||
Agile Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 8
| |||||||
Aralez Pharmaceuticals Inc.
| 10K |
$3.75 | $37,500.00 | +5.90% | 179.37K |
May 20
| |||||||
Aralez Pharmaceuticals Inc.
| 4.5K |
$3.79 | $17,037.45 | +2.73% | 169.37K |
May 16
| |||||||
Aralez Pharmaceuticals Inc.
| 47.37K |
—
|
—
| +40.31% | 164.87K |
Mar 17
| |||||||
Aralez Pharmaceuticals Inc.
| 86.86K |
—
|
—
| +283.52% | 117.5K |
Feb 12
| |||||||
Aralez Pharmaceuticals Inc.
| 30.64K |
—
|
—
|
∞
| 30.64K |
Feb 5
| |||||||
Pozen Inc /nc
| 29.14K |
—
|
—
| +1,942.47% | 30.64K |
Oct 1
| |||||||
Pozen Inc /nc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Agile Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Jun 10
| |||||||
Auxilium Pharmaceuticals Inc
| -32.63K |
$36.53 | -$1,067,991.08 | -100.00% |
0
|
Jan 29
| |||||||
Auxilium Pharmaceuticals Inc
| -3.15K |
$26.62 | -$265,997.15 | -8.99% | 31.9K |
Nov 25
| |||||||
Auxilium Pharmaceuticals Inc
| -3.65K |
$25.01 | -$1,282,581.91 | -9.43% | 35.05K |
Nov 20 - Nov 21
| |||||||
Agile Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
|
Oct 1
| |||||||
Agile Therapeutics Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Auxilium Pharmaceuticals Inc
| 27.7K |
—
|
—
| +92.52% | 57.64K |
Feb 7 - Feb 18
| |||||||
Auxilium Pharmaceuticals Inc
| 6.38K |
—
|
—
| +35.35% | 24.41K |
Feb 18
| |||||||
Auxilium Pharmaceuticals Inc
| 20.17K |
$28.30 | -$19,923.20 | +111.85% | 38.2K |
Feb 18
| |||||||
Auxilium Pharmaceuticals Inc
| -108.00 |
$26.80 | -$2,894.40 | -0.60% | 18.03K |
Feb 17
| |||||||
Auxilium Pharmaceuticals Inc
| -2.04K |
$23.68 | -$48,378.24 | -10.12% | 18.14K |
Feb 7
| |||||||
Auxilium Pharmaceuticals Inc
| 16.71K |
$18.30 | -$7,795.80 | +728.60% | 19.01K |
Feb 7
| |||||||
Auxilium Pharmaceuticals Inc
|
0
|
—
|
—
|
—
|
0
|
Feb 14
| |||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.